₹2,000 crore, it said in a regulatory filing. As part of the deal, Torrent will pay ₹115 crore in cash and cash equivalent upfront for the 100% stake.
Curatio will be valued at ₹1,885 crore. The transaction is likely to close within one month. Curatios’ team of 600 medical representatives will join Torrent Pharma and it will add a distribution network of 900 stockists. “In the last 15 years, Curatio has built a strong portfolio of differentiated products in the derma segment which are well received by both doctors and patients.
We believe Torrent is best suited to further catapult the business we have built," said Sequoia, ChrysCapital and the promotors, including GK Ramani, of Curatio in a joint statement.
In March, VCCircle had first reported that Dr Reddy’s Laboratories Ltd, Torrent Healthcare, JB Chemicals and Warburg Pincus were shortlisted to buy Curatio.
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.